High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables

Purpose. to evaluate the outcome of patients with Hodgkin's lymphoma who underwent autologous transplantation at KHCC bone marrow transplant program. Patients and Methods. Over 6 years, 63 patients with relapsed or refractory Hodgkin's lymphoma underwent high dose chemotherapy followed by...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Rahman, Fawzi, Hussein, Ayad, Aljamily, Mohammad, Al-Zaben, Abdulhadi, Hussein, Nilly, Addasi, Ala'a
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302118/
https://www.ncbi.nlm.nih.gov/pubmed/22518329
http://dx.doi.org/10.5402/2012/249124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302118/
https://www.ncbi.nlm.nih.gov/pubmed/22518329
http://dx.doi.org/10.5402/2012/249124

Ejemplares similares